Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-19

Clinical Trial Update: Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma [NA]

View source ↗

Summary

A completed clinical trial evaluating the PET tracer O-(2-[18F]-Fluoroethyl)-L-Tyrosine for diagnosis of low-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • O-(2-[18F]-Fluoroethyl)-L-Tyrosine

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Low Grade Glioma | NA | Status: COMPLETED